BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36246663)

  • 1. Comprehensive analysis of m
    Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Liu L; Jiang T
    Front Genet; 2022; 13():996950. PubMed ID: 36246663
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-omics analysis of m
    Wu X; Bai Z
    Sci Rep; 2021 Oct; 11(1):20921. PubMed ID: 34686691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M
    Chen H; Ge XL; Zhang ZY; Liu M; Wu RY; Zhang XF; Xu LP; Cheng HY; Sun XC; Zhu HC
    Transl Lung Cancer Res; 2021 May; 10(5):2172-2192. PubMed ID: 34164268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.
    Yang Q; Xu F; Jian A; Yu H; Ye T; Hu W
    Front Cell Dev Biol; 2021; 9():803141. PubMed ID: 35198565
    [No Abstract]   [Full Text] [Related]  

  • 6. m
    Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
    Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
    Ye W; Huang T
    PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
    He W; Lin G; Pan C; Li W; Shen J; Liu Y; Li H; Wu D; Lin X
    Front Genet; 2022; 13():761681. PubMed ID: 35154267
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of m
    Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
    Front Immunol; 2021; 12():782551. PubMed ID: 34975871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Wang L; Hu X; Liu X; Feng Y; Zhang Y; Han J; Liu X; Meng F
    Front Immunol; 2022; 13():1022720. PubMed ID: 36389726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation Pattern Mediated by m
    Jiang F; Hu Y; Liu X; Wang M; Wu C
    Oxid Med Cell Longev; 2022; 2022():2930310. PubMed ID: 35035657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
    Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
    Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
    Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of N6-Methyladenosine (m
    Liu D; Yuan M; Wang Z; Sun L; Fang Y; Ma X; Zhang L; Xing Y; Zhu J; Liu Y; Zhu W; Bao S; Jia Y; Wang Y
    Can J Gastroenterol Hepatol; 2022; 2022():3506518. PubMed ID: 36452120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
    Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
    Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA m
    Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
    Front Immunol; 2022; 13():905057. PubMed ID: 36389669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of m
    Pei D; Xu C; Wang D; Shi X; Zhang Y; Liu Y; Liu N; Guo J; Yu Y; Kang Z; Zhu H
    J Oncol; 2022; 2022():2910491. PubMed ID: 35281520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
    He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
    Front Genet; 2022; 13():998147. PubMed ID: 36226166
    [No Abstract]   [Full Text] [Related]  

  • 20. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma.
    Liu Z; He J; Han J; Yang J; Liao W; Chen N
    Front Immunol; 2021; 12():762243. PubMed ID: 35069534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.